Guardant Health

Conquer cancer with data.

Visit Website →

Overview

Guardant Health is a leader in precision oncology, specializing in non-invasive liquid biopsy tests. Their blood tests analyze circulating tumor DNA (ctDNA) to provide comprehensive genomic profiling for cancer patients. This approach offers a less invasive alternative to tissue biopsies and is used for therapy selection, monitoring treatment response, and detecting cancer recurrence.

✨ Key Features

  • Liquid biopsy technology
  • Comprehensive genomic profiling from blood (Guardant360)
  • Minimal residual disease (MRD) detection (Guardant Reveal)
  • Cancer screening and early detection (Guardant Shield)
  • Large real-world clinical-genomic dataset

🎯 Key Differentiators

  • Leader in liquid biopsy technology
  • Focus on early cancer detection

Unique Value: Offers a less invasive alternative to tissue biopsies for comprehensive genomic profiling.

🎯 Use Cases (4)

Therapy selection for advanced cancer patients Monitoring cancer recurrence and treatment response Early detection of cancer Drug development and clinical trial enrollment

✅ Best For

  • Guardant360 CDx is FDA-approved as a companion diagnostic for multiple targeted therapies.

💡 Check With Vendor

Verify these considerations match your specific requirements:

  • Tissue-based genomic profiling
  • Hereditary genetics

🏆 Alternatives

Foundation Medicine Tempus Caris Life Sciences

Specializes in blood-based cancer testing.

💻 Platforms

Web (Clinician Portal)

🛟 Support Options

  • ✓ Email Support
  • ✓ Phone Support
  • ✓ Dedicated Support (All tier)

🔒 Compliance & Security

✓ HIPAA ✓ BAA Available ✓ CAP accredited ✓ CLIA certified ✓ FDA approved

💰 Pricing

Contact for pricing
Visit Guardant Health Website →